ADXN Addex Therapeutics Ltd
$3.49▲ +2.95%
Healthcare
Other
After hours
$3.49▼ -3.81%
Sep 11, 4:04 PM ET
Volume 35.6K
Avg Volume (10D) 55.4K
Key Metrics & Fundamentals
Market Cap
$4.42M
P/E Ratio
–
Div Yield
–%
52W Range
3.36 - 12.05
% vs 50 MA
-32.75%
% vs 200 MA
-47.50%
RSI-14
30.9
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.73
Free Cash Flow
-$765,842
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.70M
COGS
–
Operating Exp
$479,827
Operating Income
-$479,827
EBIT
-$479,827
Pretax Income
-$1.71M
Net Income
-$1.71M
EPS (Diluted)
-1.20
Price & Volume History
Loading chart…
Recent News
ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
GlobeNewswire · Aug 26, 2026 5:00 AM
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
GlobeNewswire · Jul 8, 2026 5:00 AM
Addex Shareholders Approve All Resolutions at Annual General Meeting
GlobeNewswire · Jun 30, 2026 5:00 AM
Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
GuruFocus.com · Jun 25, 2026 9:00 PM
Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Jun 25, 2026 5:00 AM
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
GlobeNewswire · Jun 22, 2026 5:00 AM
Financial Overview - Income Statement
Quarterly
Dec 2025
See ADXN's money flow as a full page
Social Sentiment
No Reddit posts found for ADXN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.